Octapharma - Blood Disorder Treatment products (inc Haemophilia A & B)
Call off contract/order from the NHS National Framework Agreement for the supply of products for the treatment of Blood Disorders including Haemophilia A & B. Offer reference number: CM/PHS/22/5661 Specifically for products: Fibryga Octaplas
Buyer
Norfolk and Norwich University Hospitals NHS Foundation Trust
Value
£71,550
Published
12 Mar 2025
Closes
31 Dec 2024
Procurement details
Source
Contracts Finder
Region
Breckland and South Norfolk
Procurement method
Selective
Category
Goods
Contract starts
1 Jan 2025
Contract ends
30 Apr 2027
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default Octapharma - Blood Disorder Treatment products (inc Haemophilia A & B)
£71,550
Call off contract/order from the NHS National Framework Agreement for the supply of products for the treatment of Blood Disorders including Haemophilia A & B. Offer reference number: CM/PHS/22/5661 Specifically for products: Fibryga Octaplas
Delivery: East of England · United Kingdom, East of England, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
12 Mar 2025
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.